Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
GHRP-6 Acetate
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Growth Hormone › GHRP-6 Acetate
← Back to catalog Growth HormoneAvailable

GHRP-6 Acetate (10 mg)

GHRPBulkAppetite
$100 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Classic GHRP with orexigenic side effect — strongly stimulates GH release and appetite. Ideal for bulk phases.

  • Mechanism: GHRP on the ghrelin receptor; marked orexigenic effect (stimulates appetite).
  • Evidence: Mostly preclinical; older human studies on GH release.
  • In context: Raises appetite and cortisol/prolactin; GH/IGF-1 pro-growth.
Research range · SC
100–300 mcg per application · 1–3×/day
🟡 Preclinical

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundGHRP-6 Acetate
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC46H56N12O6
Molecular weight873.02 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

GHRP-6: research profile

GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) is the first growth-hormone secretagogue that worked in vivo, developed by Cyril Bowers at Tulane University and described in 1984, fifteen years before ghrelin was discovered. Its existence was in fact what led to the identification of the GHSR-1a receptor and later of its natural ligand. It is a hexapeptide with two D-amino acids that give it stability against peptidases.

It acts as a ghrelin-receptor agonist in the pituitary and hypothalamus, provoking an intense GH release that in humans is synergistic with GHRH: giving both together produces more GH than the sum of each, a 1990s finding that remains the basis of GHRH + secretagogue combinations. Unlike ipamorelin, GHRP-6 also moderately raises ACTH, cortisol and prolactin, and shares with ghrelin a marked orexigenic effect: it increases appetite quickly and noticeably.

Human studies are old and focused on the physiology of GH secretion and on diagnostic use; it was never developed as a medicine and holds no approval. Its effect on appetite, cortisol and prolactin is what drove the design of more selective secretagogues. It shares the class considerations on GH and IGF-1 and is on the World Anti-Doping Agency list. Renova distributes it as the acetate salt, for research only.

GHRP-6 technical data

ClassFirst-generation GH secretagogue (GHRP), ghrelin-receptor agonist
SequenceHis-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (hexapeptide, acetate salt)
CAS87616-84-0
OriginCyril Bowers, Tulane University, 1984
Hormonal profileReleases GH; moderately raises ACTH, cortisol and prolactin; markedly orexigenic
SynergyGHRH + GHRP-6: GH release greater than the sum (documented in humans)
Half-lifeShort (on the order of minutes to a few hours)
Regulatory statusNot approved; WADA list (S2)

Questions about GHRP-6

Why does GHRP-6 cause such hunger?

Because it activates the same receptor as ghrelin, the appetite hormone the stomach produces, in the hypothalamus. It is the compound's most recognizable effect and appears shortly after administration in studies. Later secretagogues such as ipamorelin were designed partly to avoid it.

What is the difference between GHRP-6 and ipamorelin?

Both activate the ghrelin receptor and release GH, but GHRP-6 also raises ACTH, cortisol and prolactin and stimulates appetite; ipamorelin, in Novo Nordisk's studies, altered neither those hormones nor appetite. GHRP-6 is older and less selective.

Was GHRP-6 discovered before ghrelin?

Yes, in 1984; ghrelin was identified in 1999. GHRP-6 was a designed molecule that worked without anyone knowing which receptor it acted on; the search for that receptor led to GHSR-1a (1996) and then to its natural ligand. It is a classic case of reverse pharmacology.

Is GHRP-6 combined with GHRH analogs?

In research, yes, because the two classes potentiate each other: it was precisely with GHRP-6 that the synergy with GHRH was first described in humans. In Renova's catalog the available GHRH analogs are sermorelin, Mod GRF 1-29 (CJC-1295 without DAC) and CJC-1295 with DAC.

Related reading: GHRP-6: GH Secretagogue and Ghrelin · CJC-1295 + Ipamorelin: The Most-Studied GH Stack

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty